Montréal enSanté V8N3 Été/Summer 2016 | Page 41

VACCINATION AGAINST HPV

COULD HAVE PREVENTED MY

CERVICAL

CANCER

Help protect yourself with GARDASIL®9
if you’re a woman between the ages of 9 and 45

• Cervical cancer is the 3rd most common cancer in Canadian women 20-40 years of age
• HPV is the leading cause of cervical cancer and genital warts
• It is estimated that 75% of sexually active Canadians will have at least one HPV
infection during their lifetime

Ask your healthcare professional about GARDASIL®9

www.GARDASIL9.ca

In girls and women ages 9 to 45, GARDASIL®9 helps protect against cervical, vaginal, and vulvar cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58,
abnormal and precancerous vaginal and vulvar lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58, abnormal and precancerous cervical lesions as
found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, and genital warts caused by HPV types 6 and 11. GARDASIL®9 does not treat HPV
infection. GARDASIL®9 may not fully protect each person who gets it. GARDASIL®9 does not remove the need for cervical cancer screening; women should still
get routine cervical cancer screening. GARDASIL®9 is not recommended for use in pregnant women. Like all vaccines, GARDASIL®9 may cause some side effects
and allergic reactions. Contact your doctor or healthcare professional to see if GARDASIL®9 is right for you.
HPV=human papillomavirus

Merck Sharp & Dohme Corp. Used under license.
© 2016 Merck Canada Inc. All rights reserved.

®

Member of Innovative Medicines Canada